{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T12:53:58Z","timestamp":1782564838074,"version":"3.54.5"},"reference-count":67,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2022,2,17]],"date-time":"2022-02-17T00:00:00Z","timestamp":1645056000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003329","name":"Ministry of Economy, Industry and Competitiveness","doi-asserted-by":"publisher","award":["SAF2016-75347-R"],"award-info":[{"award-number":["SAF2016-75347-R"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ministerio de Ciencia e Innovaci\u00f3n, Spain","award":["PID2019-109390RB-I00"],"award-info":[{"award-number":["PID2019-109390RB-I00"]}]},{"DOI":"10.13039\/501100002809","name":"Government of Catalonia","doi-asserted-by":"publisher","award":["2017SGR979"],"award-info":[{"award-number":["2017SGR979"]}],"id":[{"id":"10.13039\/501100002809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Changes in the molecular structure of synthetic cathinones has led to an increase in the number of novel emerging drugs in the illicit drug market at an unprecedented rate. Unfortunately, little is known about the neuropsychopharmacology of recently emerged halogen-substituted \u03b1-PVP derivatives. Thus, the aim of this study was to investigate the role of para- and meta-halogen (F-, Cl-, and Br-) substitutions on the in vitro, in silico, and in vivo effects of \u03b1-pyrrolidinopentiophenone (\u03b1-PVP) derivatives. HEK293 cells expressing the human dopamine or serotonin transporter (hDAT and hSERT) were used for the uptake inhibition and transporter affinity assays. Molecular docking was used to model the interaction mechanism against DAT. Swiss CD-1 mice were used for the horizontal locomotor activity, open field test, and conditioned place preference paradigm. All compounds demonstrated potent DA uptake inhibition and higher DAT selectivity than cocaine. Meta-substituted cathinones showed higher DAT\/SERT ratios than their para- analogs, which correlates with an increased psychostimulant effect in vivo and with different meta- and para-in silico interactions at DAT. Moreover, all compounds induced rewarding and acute anxiogenic effects in mice. In conclusion, the present study demonstrates the role of meta- and para-halogen substitutions in the mechanism of action and provides the first evidence of the rewarding and anxiety-like properties of halogenated \u03b1-PVP derivatives.<\/jats:p>","DOI":"10.3390\/ijms23042226","type":"journal-article","created":{"date-parts":[[2022,2,17]],"date-time":"2022-02-17T20:25:45Z","timestamp":1645129545000},"page":"2226","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Neuropsychopharmacology of Emerging Drugs of Abuse: meta- and para-Halogen-Ring-Substituted \u03b1-PVP (\u201cflakka\u201d) Derivatives"],"prefix":"10.3390","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9791-249X","authenticated-orcid":false,"given":"N\u00faria","family":"Nadal-Gratac\u00f3s","sequence":"first","affiliation":[{"name":"Department of Pharmacology, Toxicology and Therapeutic Chemistry, Institute of Biomedicine (IBUB), Faculty of Pharmacy and Food Science, University of Barcelona, 08028 Barcelona, Spain"},{"name":"Pharmaceutical Chemistry Group (GQF), IQS School of Engineering, Universitat Ramon Llull, 08017 Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0805-9309","authenticated-orcid":false,"given":"Esther","family":"Lleix\u00e0","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Toxicology and Therapeutic Chemistry, Institute of Biomedicine (IBUB), Faculty of Pharmacy and Food Science, University of Barcelona, 08028 Barcelona, Spain"},{"name":"Pharmaceutical Chemistry Group (GQF), IQS School of Engineering, Universitat Ramon Llull, 08017 Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00f3nica","family":"Gibert-Serrami\u00e0","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Toxicology and Therapeutic Chemistry, Institute of Biomedicine (IBUB), Faculty of Pharmacy and Food Science, University of Barcelona, 08028 Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Estrada-Tejedor","sequence":"additional","affiliation":[{"name":"Pharmaceutical Chemistry Group (GQF), IQS School of Engineering, Universitat Ramon Llull, 08017 Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Berzosa","sequence":"additional","affiliation":[{"name":"Pharmaceutical Chemistry Group (GQF), IQS School of Engineering, Universitat Ramon Llull, 08017 Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Batllori","sequence":"additional","affiliation":[{"name":"Pharmaceutical Chemistry Group (GQF), IQS School of Engineering, Universitat Ramon Llull, 08017 Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6627-4501","authenticated-orcid":false,"given":"David","family":"Pubill","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Toxicology and Therapeutic Chemistry, Institute of Biomedicine (IBUB), Faculty of Pharmacy and Food Science, University of Barcelona, 08028 Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Camarasa","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Toxicology and Therapeutic Chemistry, Institute of Biomedicine (IBUB), Faculty of Pharmacy and Food Science, University of Barcelona, 08028 Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5078-366X","authenticated-orcid":false,"given":"Elena","family":"Escubedo","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Toxicology and Therapeutic Chemistry, Institute of Biomedicine (IBUB), Faculty of Pharmacy and Food Science, University of Barcelona, 08028 Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8904-7398","authenticated-orcid":false,"given":"Ra\u00fal","family":"L\u00f3pez-Arnau","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Toxicology and Therapeutic Chemistry, Institute of Biomedicine (IBUB), Faculty of Pharmacy and Food Science, University of Barcelona, 08028 Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,2,17]]},"reference":[{"key":"ref_1","unstructured":"European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) (2021). European Drug Report: Trends and Developments."},{"key":"ref_2","unstructured":"United Nations Office on Drugs and Crime (UNODC) (2021). World Drug Report 2021. Global Overview: Drug Demand Drug Supply, United Nations Publication. Sales No. E.21.XI.8."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s11419-017-0385-6","article-title":"The newest cathinone derivatives as designer drugs: An analytical and toxicological review","volume":"36","author":"Majchrzak","year":"2018","journal-title":"Forensic Toxicol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1177\/0269881110378370","article-title":"Instability of the ecstasy market and a new kid on the block: Mephedrone","volume":"25","author":"Brunt","year":"2011","journal-title":"J. Psychopharmacol."},{"key":"ref_5","unstructured":"Drug Enforcement Administration (DEA) (2013). Establishment of drug codes for 26 substances. Final Rule. Fed. Regist., 78, 664\u2013666."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.forsciint.2016.01.037","article-title":"A snapshot on NPS in Italy: Distribution of drugs in seized materials analysed in an Italian forensic laboratory in the period 2013\u20132015","volume":"265","author":"Odoardi","year":"2016","journal-title":"Forensic Sci. Int."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"e2621","DOI":"10.1002\/hup.2621","article-title":"Patterns of use and toxicity of new para-halogenated substituted cathinones: 4-CMC (clephedrone), 4-CEC (4-chloroethcatinone) and 4-BMC (brephedrone)","volume":"32","author":"Grifell","year":"2017","journal-title":"Hum. Psychopharmacol. Clin. Exp."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.forsciint.2017.04.007","article-title":"Brephedrone: A new psychoactive substance seized in Brazil","volume":"275","author":"Machado","year":"2017","journal-title":"Forensic Sci. Int."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1007\/s00204-020-02693-7","article-title":"Designer drugs: Mechanism of action and adverse effects","volume":"94","author":"Luethi","year":"2020","journal-title":"Arch. Toxicol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/FTD.0000000000000808","article-title":"A Review of Synthetic Cathinone-Related Fatalities From 2017 to 2020","volume":"43","author":"Giorgetti","year":"2021","journal-title":"Ther. Drug Monit."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s11419-015-0298-1","article-title":"a-PVP (\u201cflakka\u201d\u2019): A new synthetic cathinone invades the drug arena","volume":"34","author":"Katselou","year":"2016","journal-title":"Forensic Toxicol."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Patocka, J., Zhao, B., Wu, W., Klimova, B., Valis, M., Nepovimova, E., and Kuca, K. (2020). Flakka: New Dangerous Synthetic Cathinone on the Drug Scene. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21218185"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1038\/s41386-018-0209-3","article-title":"The abuse-related effects of pyrrolidine-containing cathinones are related to their potency and selectivity to inhibit the dopamine transporter","volume":"43","author":"Gannon","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"108475","DOI":"10.1016\/j.neuropharm.2021.108475","article-title":"Role of amino terminal substitutions in the pharmacological, rewarding and psychostimulant profiles of novel synthetic cathinones","volume":"186","author":"Muralter","year":"2021","journal-title":"Neuropharmacology"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1124\/jpet.116.236349","article-title":"Structure-Activity Relationships of Substituted Cathinones, with Transporter Binding, Uptake, and Release","volume":"360","author":"Eshleman","year":"2017","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s00213-013-2967-2","article-title":"Mephedrone and methylenedioxypyrovalerone (MDPV), major constituents of \u201cbath salts,\u201d produce opposite effects at the human dopamine transporter","volume":"227","author":"Cameron","year":"2013","journal-title":"Psychopharmacology"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1124\/jpet.115.223586","article-title":"Comparative Behavioral Pharmacology of Three Pyrrolidine-Containing Synthetic Cathinone Derivatives","volume":"354","author":"Gatch","year":"2015","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s00213-016-4492-6","article-title":"Self-administration and behavioral economics of second-generation synthetic cathinones in male rats","volume":"234","author":"Huskinson","year":"2017","journal-title":"Psychopharmacology"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ijcard.2013.12.262","article-title":"Sudden death after sustained restraint following self-administration of the designer drug \u03b1-pyrrolidinovalerophenone","volume":"172","author":"Nagai","year":"2014","journal-title":"Int. J. Cardiol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/1556-4029.13326","article-title":"Fatal Intoxication with \u03b1-PVP, a Synthetic Cathinone Derivative","volume":"62","author":"Janus","year":"2017","journal-title":"J. Forensic Sci."},{"key":"ref_21","unstructured":"(2015). EMCDDA-Europol Joint Report on a New Psychoactive Substance: 1-Phenyl-2-(1-pyrrolidinyl)-1-Pentanone (\u03b1-PVP), Publications Office of the European Union. Joint Reports."},{"key":"ref_22","unstructured":"Drug Enforcement Administration (DEA) (2021, September 10). Temporary Placement of 10 Synthetic Cathinones into Schedule I, Available online: https:\/\/www.deadiversion.usdoj.gov\/fed_regs\/rules\/2014\/fr0128.htm."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.forsciint.2014.03.013","article-title":"Characterization of four new designer drugs, 5-chloro-NNEI, NNEI indazole analog, \u03b1-PHPP and \u03b1-POP, with 11 newly distributed designer drugs in illegal products","volume":"243","author":"Uchiyama","year":"2014","journal-title":"Forensic Sci. Int."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1080\/15563650.2017.1370097","article-title":"Intoxications in the STRIDA project involving a panorama of psychostimulant pyrovalerone derivatives, MDPV copycats","volume":"56","author":"Beck","year":"2018","journal-title":"Clin. Toxicol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.forsciint.2019.02.029","article-title":"New psychoactive substances in oral fluid of drivers around a music festival in south-west France in 2017","volume":"297","author":"Richeval","year":"2019","journal-title":"Forensic Sci. Int."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"110888","DOI":"10.1016\/j.forsciint.2021.110888","article-title":"Detection of 4-FMC, 4-MeO-\u03b1-PVP, 4-F-\u03b1-PVP, and PV8 in blood in a forensic case using liquid chromatography-electrospray ionization linear ion trap mass spectrometry","volume":"325","author":"Mochizuki","year":"2021","journal-title":"Forensic Sci. Int."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1007\/s11419-017-0381-x","article-title":"Spectroscopic characterization and crystal structures of two cathinone derivatives: 1-(4-chlorophenyl)-2-(1-pyrrolidinyl)-pentan-1-one (4-chloro-\u03b1-PVP) sulfate and 1-(4-methylphenyl)-2-(dimethylamino)-propan-1-one (4-MDMC) hydrochloride salts, seized on illicit drug market","volume":"36","author":"Kusz","year":"2018","journal-title":"Forensic Toxicol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s11419-017-0360-2","article-title":"Identification and structural characterization of four novel synthetic cathinones: \u03b1-methylaminohexanophenone (hexedrone, HEX), 4-bromoethcathinone (4-BEC), 4-chloro-\u03b1-pyrrolidinopropiophenone (4-Cl-PPP), and 4-bromo-\u03b1-pyrrolidinopentiophenone (4-Br-PVP) after their seizures","volume":"35","author":"Bednarek","year":"2017","journal-title":"Forensic Toxicol."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Pieprzyca, E., Skowronek, R., and Czekaj, P. (2021). Toxicological Analysis of Cases of Mixed Poisonings with Synthetic Cathinones and other Drugs of Abuse. Online ahead of print. J. Anal. Toxicol., bkab119.","DOI":"10.1093\/jat\/bkab119"},{"key":"ref_30","unstructured":"Drug Enforcement Administration (DEA) (2021, September 13). Temporary Placement of N-Ethylhexedrone, [alpha]-PHP, 4-MEAP, MPHP, PV8, and 4-Chloro-[alpha]-PVP in Schedule I, Available online: https:\/\/www.deadiversion.usdoj.gov\/fed_regs\/rules\/2019\/fr0501.htm."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1021\/jm050797a","article-title":"1- (4-Methylphenyl) -2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) Analogues: A Promising Class of Monoamine Uptake Inhibitors","volume":"49","author":"Meltzer","year":"2006","journal-title":"J. Med. Chem."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1007\/s00213-018-5059-5","article-title":"Structure-activity relationships of bath salt components: Substituted cathinones and benzofurans at biogenic amine transporters","volume":"236","author":"Eshleman","year":"2019","journal-title":"Psychopharmacology"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1007\/s12640-020-00227-8","article-title":"Four Synthetic Cathinones: 3-Chloromethcathinone, 4-Chloromethcathinone, 4-Fluoro-\u03b1-Pyrrolidinopentiophenone, and 4-Methoxy-\u03b1-Pyrrolidinopentiophenone Produce Changes in the Spontaneous Locomotor Activity and Motor Performance in Mice with Varied Profiles","volume":"38","author":"Wojcieszak","year":"2020","journal-title":"Neurotox Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1002\/minf.201400195","article-title":"Perspectives of Halogen Bonding Description in Scoring Functions and QSAR\/QSPR: Substituent Effects in Aromatic Core","volume":"34","author":"Titov","year":"2015","journal-title":"Mol. Inform."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1016\/j.bcp.2013.04.004","article-title":"Substituted methcathinones differ in transporter and receptor interactions","volume":"85","author":"Eshleman","year":"2013","journal-title":"Biochem. Pharmacol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/7854_2016_18","article-title":"Decoding the Structure of Abuse Potential for New Psychoactive Substances: Structure-Activity Relationships for Abuse-Related Effects of 4-Substituted Methcathinone Analogs","volume":"32","author":"Negus","year":"2017","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1021\/acschemneuro.8b00524","article-title":"Systematic structure-activity studies on selected 2-, 3-, and 4-monosubstituted synthetic methcathinone analogs as monoamine transporter releasing agents","volume":"10","author":"Walther","year":"2019","journal-title":"ACS Chem. Neurosci."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1111\/bph.13030","article-title":"Quantitative structure-activity relationship analysis of the pharmacology of para-substituted methcathinone analogues","volume":"172","author":"Bonano","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"438","DOI":"10.3389\/fphar.2019.00438","article-title":"Para-Halogenation Affects Monoamine Transporter Inhibition Properties and Hepatocellular Toxicity of Amphetamines and Methcathinones","volume":"10","author":"Luethi","year":"2019","journal-title":"Front. Pharmacol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.euroneuro.2014.12.012","article-title":"Monoamine transporter and receptor interaction profiles of novel psychoactive substances: Para-halogenated amphetamines and pyrovalerone cathinones","volume":"25","author":"Rickli","year":"2015","journal-title":"Eur. Neuropsychopharmacol."},{"key":"ref_41","first-page":"e52434","article-title":"Use of the Open Field Maze to measure locomotor and anxiety-like behavior in mice","volume":"96","author":"Seibenhener","year":"2015","journal-title":"J. Vis. Exp."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1097\/FBP.0000000000000484","article-title":"Effects of N-ethylpentylone on locomotor activity and anxiety-like behavior in rats","volume":"30","author":"Li","year":"2019","journal-title":"Behav. Pharmacol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"232","DOI":"10.3389\/fpsyt.2017.00232","article-title":"Pharmacokinetic, Ambulatory, and Hyperthermic Effects of 3,4-Methylenedioxy-N-Methylcathinone (Methylone) in Rats","volume":"8","author":"Horsley","year":"2017","journal-title":"Front. Psychiatry"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.pneurobio.2004.09.004","article-title":"Mesolimbic dopaminergic pathways in fear conditioning","volume":"74","author":"Pezze","year":"2004","journal-title":"Prog. Neurobiol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.neubiorev.2017.05.008","article-title":"Core, social and moral disgust are bounded: A review on behavioral and neural bases of repugnance in clinical disorders","volume":"80","author":"Vicario","year":"2017","journal-title":"Neurosci. Biobehav. Rev."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.3389\/fpsyg.2018.02201","article-title":"Emotional Roles of Mono-Aminergic Neurotransmitters in Major Depressive Disorder and Anxiety Disorders","volume":"9","author":"Liu","year":"2018","journal-title":"Front. Psychol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/0091-3057(92)90386-T","article-title":"Anxiogenic effects of acute and chronic cocaine administration: Neurochemical and behavioral studies","volume":"41","author":"Yang","year":"1992","journal-title":"Pharmacol. Biochem. Behav."},{"key":"ref_48","first-page":"636","article-title":"Amphetamine-induced anxiety-related behavior in animal models","volume":"59","author":"Kruk","year":"2007","journal-title":"Pharmacol. Rep."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"113186","DOI":"10.1016\/j.bbr.2021.113186","article-title":"The acute effects of multiple doses of methamphetamine on locomotor activity and anxiety-like behavior in adolescent and adult mice","volume":"405","author":"Ortman","year":"2021","journal-title":"Behav. Brain Res."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.neubiorev.2018.07.015","article-title":"Abuse potential and toxicity of the synthetic cathinones (i.e., \u201cBath salts\u201d)","volume":"110","author":"Riley","year":"2020","journal-title":"Neurosci. Biobehav. Rev."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s002130000569","article-title":"Conditioned place preference: What does it add to our preclinical understanding of drug reward?","volume":"153","author":"Bardo","year":"2000","journal-title":"Psychopharmacology"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1369-1600.2007.00070.x","article-title":"Measuring reward with the conditioned place preference (CPP) paradigm: Update of the last decade","volume":"12","author":"Tzschentke","year":"2007","journal-title":"Addict. Biol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1111\/bph.13771","article-title":"Exposure of adolescent mice to 3,4-methylenedioxypyrovalerone increases the psychostimulant, rewarding and reinforcing effects of cocaine in adulthood","volume":"174","author":"Pubill","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1124\/mol.64.2.430","article-title":"Dissociation of high-affinity cocaine analog binding and dopamine uptake inhibition at the dopamine transporter","volume":"64","author":"Wang","year":"2003","journal-title":"Mol. Pharmacol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1124\/jpet.105.085829","article-title":"Recognition of benztropine by the dopamine transporter (DAT) differs from that of the classical dopamine uptake inhibitors cocaine, methylphenidate, and mazindol as a function of a DAT transmembrane 1 aspartic acid residue","volume":"314","author":"Ukairo","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/med.10014","article-title":"Probes for the dopamine transporter: New leads toward a cocaine-abuse therapeutic\u2014A focus on analogues of benztropine and rimcazole","volume":"22","author":"Newman","year":"2002","journal-title":"Med. Res. Rev."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1523\/JNEUROSCI.4778-04.2005","article-title":"Identification of a dopamine transporter ligand that blocks the stimulant effects of cocaine","volume":"25","author":"Desai","year":"2005","journal-title":"J. Neurosci."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Niello, M., Sideromenos, S., Gradisch, R., O\u2019Shea, R., Schwazer, J., Sandtner, W., Maier, J., J\u00e4ntsch, K., Lupica, C., and Hoffman, A. (2021). Psychomotor stimulant effects of \u03b1-pyrrolidinovalerophenone (\u03b1PVP) enantiomers correlate with drug binding kinetics at the dopamine transporter. Res. Sq., 1\u201325.","DOI":"10.21203\/rs.3.rs-612345\/v1"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1113\/EP088870","article-title":"The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research","volume":"105","author":"Hurst","year":"2020","journal-title":"Exp. Physiol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/7854_2016_63","article-title":"Application of a Combined Approach to Identify New Psychoactive Street Drugs and Decipher Their Mechanisms at Monoamine Transporters","volume":"32","author":"Mayer","year":"2016","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"ref_61","first-page":"2766","article-title":"Structure\u2013Activity Relationship of Novel Second-Generation Synthetic Cathinones: Mechanism of Action, Locomotion, Reward, and Immediate-Early Genes","volume":"12","author":"Urquizu","year":"2021","journal-title":"Front. Pharmacol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"10924","DOI":"10.1074\/jbc.M109.083154","article-title":"The N terminus of monoamine transporters is a lever required for the action of amphetamines","volume":"285","author":"Sucic","year":"2010","journal-title":"J. Biol. Chem."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/nature14431","article-title":"Neurotransmitter and psychostimulant recognition by the dopamine transporter","volume":"521","author":"Wang","year":"2015","journal-title":"Nature"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1016\/0006-2952(73)90196-2","article-title":"Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction","volume":"22","author":"Cheng","year":"1973","journal-title":"Biochem. Pharmacol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1080\/15563650.2017.1301463","article-title":"Synthetic cathinones in Southern Germany\u2014characteristics of users, substance-patterns, co-ingestions, and complications","volume":"55","author":"Romanek","year":"2017","journal-title":"Clin. Toxicol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3389\/fpsyt.2017.00156","article-title":"Synthetic Cathinone and Cannabinoid Designer Drugs Pose a Major Risk for Public Health","volume":"8","author":"Weinstein","year":"2017","journal-title":"Front. Psychiatry"},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Lauritzen, G., and Nordfj\u00e6rn, T. (2018). Changes in opiate and stimulant use through 10 years: The role of contextual factors, mental health disorders and psychosocial factors in a prospective SUD treatment cohort study. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0190381"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/4\/2226\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:21:39Z","timestamp":1760134899000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/4\/2226"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,17]]},"references-count":67,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2022,2]]}},"alternative-id":["ijms23042226"],"URL":"https:\/\/doi.org\/10.3390\/ijms23042226","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,17]]}}}